Key result
Metabolic syndrome was independently associated with a significantly higher odds of major ischemia presentation on ECG (OR 1.254) compared to individuals without metabolic syndrome.
Why the study?
The exact association between metabolic syndrome components and ischemic ECG abnormalities is not well established.
Is metabolic syndrome associated with ischemic ECG presentations in adults aged 35-65 years?
Cross-Sectional (n=9,035)
Is metabolic syndrome associated with ischemic ECG presentations in adults aged 35-65 years?
Odds Ratio: 1.254 (95% CI 1.103–1.425)
Absolute Event Rate: 16.5% vs 12.6%
p-value: p=<0.001
Metabolic syndrome is independently associated with major ischemic ECG changes in a population-based cohort, highlighting its role in subclinical cardiovascular disease.
Association of MetS components with ischemic ECG changes is hypothesis-generating; prospective studies needed before clinical adoption.
Background Metabolic syndrome (MetS) is a set of metabolic impairments that are all risk factors for cardiovascular diseases (CVDs). To distinguish and anticipate the CVD risk, an electrocardiogram (ECG) can be utilized. While the exact association between MetS components and ECG abnormalities isn’t well established yet, we designed this study to verify the association between MetS components and ischemic ECG presentations. Methods This cross-sectional study was conducted on individuals aged 35–65 years as part of the population-based Mashhad stroke and heart atherosclerotic disorder (MASHAD) study. International Diabetes Federation (IDF) criteria were utilized to categorize the participants into two groups: those with and without MetS. ECGs were coded using the Minnesota coding system. The association between each MetS component and every single ischemic ECG presentation was analysed separately. Results Among the 9035 available ECG data, the general prevalence of ischemic ECG presentation was significantly higher in those with MetS than in those without (p < 0.05), except for minor ischemia (P = 0.787). Multiple logistic regression analysis showed that MetS was independently associated with major ischemia presentation in ECG (OR = 1.254, 95% Cl: 1.103–1.425, P < 0.001), but there wasn’t any association found with minor ischemia, after adjustment for age, sex, smoking, CVD family history, and physical activity level. Among Mets components, triglycerides, fasting blood glucose, waist circumference, and systolic and diastolic blood pressures had significantly positive associations with ischemic ECG presentations in the case of any association. Elevated high-density lipoprotein cholesterol level had negative associations with ischemic ECG presentations, while it had a significant positive association only with ST-segment elevation (OR = 1.021, 95% Cl: 1.011–1.031, P < 0.001). Conclusions MetS and its components showed an association with ischemic ECG presentations, but these associations were diverse, based on each MetS component and ischemic ECG abnormality.
No takes yet. Share an insight, caveat, or question.
Soflaei et al. (2023) conducted a cross-sectional in Metabolic Syndrome and Ischemic ECG Changes (n=9,035). Metabolic syndrome vs. Without metabolic syndrome was evaluated on Major ischemia presentation in ECG (OR 1.254, 95% CI 1.103-1.425, p=<0.001). Metabolic syndrome was independently associated with a significantly higher odds of major ischemia presentation on ECG (OR 1.254) compared to individuals without metabolic syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: